HTA Council Preliminary Recommendation on Pembrolizumab and Atezolizumab for Non-Small Cell Lung Cancer (NSCLC)

As of 12 March 2026, the Health Technology Assessment Council has completed the evidence appraisal on the assessment of Pembrolizumab (100 mg/4 mL [25 mg/mL] solution for IV infusion) and Atezolizumab (1200 mg/20 mL [60 mg/mL] concentrate for solution for IV infusion) for the first-line treatment of patients with metastatic non–small cell lung cancer (NSCLC) continue reading : HTA Council Preliminary Recommendation on Pembrolizumab and Atezolizumab for Non-Small Cell Lung Cancer (NSCLC)

Announcement of Vacancy

The Health Technology Assessment (HTA) Council invites qualified individuals to apply for the position of Executive Director III Interested and eligible applicants may submit their application requirements via email to ousec.sts@dost.gov.ph on or before 23 February 2026.

CALL FOR EXPRESSION OF INTEREST: HTA Research Agenda Program [HTA Research Topics 2025 – Batch 1] [CLOSED]

Note: This call for proposals closed on 18 November 2025. The Health Technology Assessment (HTA) Philippines invites interested researchers to express interest and submit capsule proposals under the 2025 HTA Topics – Batch 1 Call [HTA General Track – Cycle 1 and Cycle 2 Clinical assessments; Pre-Cycle 1, Cycle 1, and Cycle 2 topics for Economic continue reading : CALL FOR EXPRESSION OF INTEREST: HTA Research Agenda Program [HTA Research Topics 2025 – Batch 1] [CLOSED]

The Secretary of Health (SOH) fully concurs with the HTA Council Final Recommendations for the Government Financing of 12 health technologies

On 11 August 2025, the Secretary of Health (SOH) fully concurs with the Health Technology Council recommendation on the government financing of the following health technologies, through the Department of Health (DOH) Department Circulars 2025-0338, 2025-0339, and 2025-0340: For the full details on the HTA Council Final Recommendation, such as considerations and evidence, please see continue reading : The Secretary of Health (SOH) fully concurs with the HTA Council Final Recommendations for the Government Financing of 12 health technologies